ICT Priorities in Pharmaceuticals

Transcription

1 ICT Priorities in Pharmaceuticals Enterprise ICT investment plans December 2013

2 TABLE OF CONTENTS 1 1 Enterprise ICT investment trends Introduction Survey demographics ICT budget changes Strategic objectives Core technology investment priorities Detailed ICT investment priorities Introduction Enterprise applications Business intelligence Security Content management Mobility IT systems management Communications & collaboration Green IT & virtualization Cloud computing solutions Summary Intense competition among pharmaceutical companies is driving the adoption of advanced technologies such as cloud and tablet computing Appendix Definitions Further reading Contact the authors ICT Priorities in Pharmaceuticals P a g e 2 / Kable Business Intelligence Limited / + 44 (0)

3 List of Figures Figure 1: Pharmaceuticals enterprise ICT survey geographic breakdown... 5 Figure 2: Pharmaceuticals enterprise ICT survey breakdown by size band (number of employees)... 7 Figure 3: Recent and expected ICT budget changes among pharmaceutical companies... 8 Figure 4: Current strategic objectives of pharmaceutical companies Figure 5: Current and future investment priorities of pharmaceutical companies across core technologies Figure 6: Enterprise applications pharmaceutical companies current and future investment priorities 14 Figure 7: Business intelligence pharmaceutical companies current and future investment priorities Figure 8: Security pharmaceutical companies current and future investment priorities Figure 9: Content management pharmaceutical companies current and future investment priorities.. 20 Figure 10: Mobility pharmaceutical companies current and future investment priorities Figure 11: IT systems management pharmaceutical companies current and future investment priorities Figure 12: Communications & collaboration pharmaceutical companies current and future investment priorities Figure 13: Green IT & virtualization pharmaceutical companies current and future investment priorities Figure 14: Cloud computing solutions pharmaceutical companies current and future investment priorities List of Tables Table 1: Pharmaceuticals enterprise ICT survey geographic breakdown... 6 Table 2: Pharmaceuticals enterprise ICT survey breakdown by size band (number of employees)... 7 Table 3: Recent and expected ICT budget changes among pharmaceutical companies... 8 Table 4: Current strategic objectives of pharmaceutical companies Table 5: Current and future investment priorities of pharmaceutical companies across core technologies Table 6: Enterprise applications pharmaceutical companies current and future investment priorities.. 15 Table 7: Business intelligence pharmaceutical companies current and future investment priorities Table 8: Security pharmaceutical companies current and future investment priorities Table 9: Content management pharmaceutical companies current and future investment priorities Table 10: Mobility pharmaceutical companies current and future investment priorities Table 11: IT systems management pharmaceutical companies current and future investment priorities Table 12: Communications & collaboration pharmaceutical companies current and future investment priorities Table 13: Green IT & virtualization pharmaceutical companies current and future investment priorities Table 14: Cloud computing solutions pharmaceutical companies current and future investment priorities ICT Priorities in Pharmaceuticals P a g e 3 / Kable Business Intelligence Limited / + 44 (0)

4 1 Enterprise ICT investment trends 1.1 Introduction This report presents the findings from a survey of pharmaceutical companies regarding their Information & Communications Technology (ICT) investment priorities. The survey investigates the core technologies which pharmaceutical companies are investing in, including the likes of enterprise applications, security, mobility, communications & collaboration, and cloud computing. The report also highlights pharmaceutical companies strategic objectives with regards to their ICT investments, in order to provide better insight to ICT vendors relating to the positioning of their solutions. ICT investment trends are identified through to the second half of 2014 following feedback from respondents on their forthcoming investment plans. The survey was conducted in September 2012 via an online methodology, with respondents all having ICT decision maker responsibility (typically CIOs and IT Managers). Kable plans to repeat the survey in the second half of 2013, in order to monitor ICT investment priorities on an ongoing basis. 1.2 Survey demographics Figure 1: Pharmaceuticals enterprise ICT survey geographic breakdown Pharmaceuticals - enterprise ICT survey geographic breakdown US France Germany Spain UK Italy Middle East Australia Others respondents ICT Priorities in Pharmaceuticals P a g e 4 / Kable Business Intelligence Limited / + 44 (0)

5 Table 1: Pharmaceuticals enterprise ICT survey geographic breakdown Geography Count Percentage of respondents US France Germany UK Spain Italy Middle East Australia Denmark Netherlands Switzerland Norway Belgium Sweden Canada Finland Total ICT Priorities in Pharmaceuticals P a g e 5 / Kable Business Intelligence Limited / + 44 (0)

6 Figure 2: Pharmaceuticals enterprise ICT survey breakdown by size band (number of employees) Pharmaceuticals enterprise ICT survey breakdown by size band Over respondents Table 2: Pharmaceuticals enterprise ICT survey breakdown by size band (number of employees) Employee size band Count Percentage of respondents Over % % % % % % % Total % ICT Priorities in Pharmaceuticals P a g e 6 / Kable Business Intelligence Limited / + 44 (0)

7 1.4 Strategic objectives Figure 3: Current strategic objectives of pharmaceutical companies What are your major strategic objectives this year? Improving security/privacy Systems simplification Standardizing infrastructure technologies Encouraging more IT self service Enhancing collaboration and data management Moving to a virtual infrastructure End-to-end business transformation projects Moving towards a shared services model Business process outsourcing Average rating (1 = not an objective, 4 = top priority) x respondents Table 3: Current strategic objectives of pharmaceutical companies Strategic objectives Improving security/privacy Systems simplification Standardizing infrastructure technologies Encouraging more IT self service Enhancing collaboration and data management Moving to a virtual infrastructure End-to-end business transformation projects Moving towards a shared services model Business process outsourcing Average rating A large number of pharmaceutical companies are using IT as a business enabler and... (A brief description of the strategic objectives that are driving ICT investments in pharmaceutical companies) ICT Priorities in Pharmaceuticals P a g e 7 / Kable Business Intelligence Limited / + 44 (0)

8 1.5 Core technology investment priorities Figure 4: Current and future investment priorities of pharmaceutical companies across core technologies ICT Priorities in Pharmaceuticals P a g e 8 / Kable Business Intelligence Limited / + 44 (0)

9 Table 4: Current and future investment priorities of pharmaceutical companies across core technologies Technology category Have now (Count) Have now (%) Considering investment in next 2 years (count) Considering investment in next 2 years (%) Security IT systems management Green IT & virtualization Enterprise applications Communications & collaboration Content management Mobility Business intelligence Cloud Computing According to the survey, security technologies have the highest penetration rate,...(brief description of which technologies pharmaceutical companies are currently investing in, as well as those that they are set to make the greatest investments in, in the next couple of years) ICT Priorities in Pharmaceuticals P a g e 9 / Kable Business Intelligence Limited / + 44 (0)

10 2 Detailed ICT investment priorities 2.1 Introduction In addition to identifying ICT investment priorities within core enterprise technology categories, Kable s survey also drills into depth as to how pharmaceutical companies are planning to make investments at the more detailed sub category level. This section of the report focuses on pharmaceutical companies technology investment priorities within the enterprise applications, business intelligence, security, content management, mobility, IT systems management, communications & collaboration, green IT & virtualization, and cloud computing categories. 2.2 Enterprise Applications Figure 5: Enterprise Applications pharmaceutical companies current and future investment priorities ICT Priorities in Pharmaceuticals P a g e 10 / Kable Business Intelligence Limited / + 44 (0)

11 Table 5: Enterprise Applications pharmaceutical companies current and future investment priorities Enterprise applications Have now (count) Have now (%) Considering investment in next 2 years (count) Considering investment in next 2 years (%) HR Management Customer Relationship Management (CRM) Financials Enterprise Resource Planning (ERP) Supply Chain Management (SCM) Product Lifecycle Management (PLM) Marketing Automation & Customer Lifecycle Management (CLM) Business Process Management (BPM) The demand for enterprise applications is growing in pharmaceutical companies; such applications enable companies to manage their operations more effectively by providing... (Briefly describe in which sub categories pharmaceutical companies are planning on making investments). ICT Priorities in Pharmaceuticals P a g e 11 / Kable Business Intelligence Limited / + 44 (0)

12 4 Appendix 4.1 Definitions Enterprise technologies Enterprise applications core enterprise applications include the likes of Customer Relationship Management (CRM), Enterprise Resource Planning (ERP), Financials, Supply Chain Management, HR Management, Product Lifecycle Management, Business Process Management (BPM), Interactive marketing automation systems & customer lifecycle management. Business intelligence covers Data warehousing/marts, Analytics, Real-time Business Intelligence, Social sentiment analysis. Security includes Identity & access management, Security & vulnerability management, End-point security & anti-virus, Network security, Content and web filtering (including firewalls), Application Security, Backup & archive, Database security, Data Loss Prevention (mobile security). Content management covers Document Management, Records Management, Web Content Management, Digital Asset Management, Archiving, and Enterprise Search. Mobility covers Mobile device management, Customer facing mobile applications/m-commerce, Employee / supplier facing mobile applications & development/integration, Tablet computing. IT systems management covers Systems & network management, Storage management, Service management, Database management, Transaction performance management, User experience management, Virtualization management, Patch management & configuration. Communications & collaboration includes Internet Protocol-Private Branch Exchange (IP-PB), IP-Contact Centre, Unified Communications: VoIP/Presence/Instant messaging, Web/video conferencing. Green IT & virtualization covers Server virtualization, Storage virtualization, Network virtualization, Datacentre power and cooling reduction technologies, Desktop virtualization, Power management tool for PCs and monitors, Printing and paper usage management. Cloud Computing covers Infrastructure as a Service (IaaS), Platform as a Service (PaaS), Software as a Service (SaaS), Private Cloud, and Hybrid cloud (mixed cloud & on-premise models). ICT Priorities in Pharmaceuticals P a g e 12 / Kable Business Intelligence Limited / + 44 (0)